Brignola C, De Simone G, Iannone P, Belloli C, Evangelisti A, Campieri M, Belluzzi A, Gionchetti P, Tampieri M, Bertinelli E
Istituto di Clinica Medica e Gastroenterologia, Clinica-Università di Bologna.
Agents Actions. 1992;Spec No:C90-2.
Steroids are very useful drugs in the treatment of active Crohn's disease (CD), but clinical relapses after steroid withdrawal may be very high. We investigated the efficacy of two steroid regimens of different duration in inducing remission and in maintaining it after drug suspension. Patients with active CD were randomly assigned to scheme A, lasting 7 weeks (27 patients), or to scheme B, lasting 15 weeks (27 patients). Remission rates at the end of the treatment were 81% for scheme A and 85% for scheme B. Relapse rates at 6 months after stopping the treatment were 50% (11 patients) and 52% (12 patients), respectively. Remission rates seem not to be influenced by the duration of the treatment, but patients recently treated with steroids showed a higher relapse rate if they received the short-duration treatment.
类固醇是治疗活动期克罗恩病(CD)的非常有用的药物,但停用类固醇后临床复发率可能很高。我们研究了两种不同疗程的类固醇方案在诱导缓解及停药后维持缓解方面的疗效。活动期CD患者被随机分配至方案A(持续7周,27例患者)或方案B(持续15周,27例患者)。治疗结束时方案A的缓解率为81%,方案B为85%。停药后6个月的复发率分别为50%(11例患者)和52%(12例患者)。缓解率似乎不受治疗疗程的影响,但近期接受过类固醇治疗的患者若接受短疗程治疗则复发率较高。